Pharmaceuticals

Europe Non-Insulin Therapies for Diabetes Market Report 2017

  • QYR908355
  • 124 Pages
  • February 2017
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Non-Insulin Therapies for Diabetes

Revenue, means the sales value of Non-Insulin Therapies for Diabetes

This report studies sales (consumption) of Non-Insulin Therapies for Diabetes in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

GSK

Eli Lilly

Sumitomo Dainippon Pharma

Intarcia Therapeutics

Servier

Jiangsu Hansoh Pharmaceutical

Novo Nordisk

Emisphere

Uni-Bio Science Group

Takeda

3SBio

Merck

Dong-A Pharmaceutical

Luye Pharma Group

Eurofarma

Geropharm

Alkem Labs

SatRx

Pfizer

Jiangsu Hengrui Medicine

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Non-Insulin Therapies for Diabetes in these countries, from 2011 to 2021 (forecast), like

Germany

France

UK

Russia

Italy

Spain

Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

Alpha-Glucosidase Inhibitors

Amylin Agonists

Biguanides

Dipeptidyl Peptidase-4 (DPP4) Inhibitors

Glinides/Meglitinides

GLP-1 Analogs/GLP-1 Agonists

Sodium-Glucose Cotransporter2(SGLT2)Inhibitors

Sulfonylureas

Thiazolidinediones

Others

Split by application, this report focuses on sales, market share and growth rate of Non-Insulin Therapies for Diabetes in each application, can be divided into

Hospital Pharmacy

Retail Pharmacies

Online Pharmacy

Others

Table of Contents

Europe Non-Insulin Therapies for Diabetes Market Report 2017

1 Non-Insulin Therapies for Diabetes Overview

1.1 Product Overview and Scope of Non-Insulin Therapies for Diabetes

1.2 Classification of Non-Insulin Therapies for Diabetes

1.2.1 Alpha-Glucosidase Inhibitors

1.2.2 Amylin Agonists

1.2.3 Biguanides

1.2.4 Dipeptidyl Peptidase-4 (DPP4) Inhibitors

1.2.5 Glinides/Meglitinides

1.2.6 GLP-1 Analogs/GLP-1 Agonists

1.2.7 Sodium-Glucose Cotransporter2(SGLT2)Inhibitors

1.2.8 Sulfonylureas

1.2.9 Thiazolidinediones

1.2.10 Others

1.3 Application of Non-Insulin Therapies for Diabetes

1.3.1 Hospital Pharmacy

1.3.2 Retail Pharmacies

1.3.3 Online Pharmacy

1.3.4 Others

1.4 Non-Insulin Therapies for Diabetes Market by Countries

1.4.1 Germany Status and Prospect (2012-2022)

1.4.2 France Status and Prospect (2012-2022)

1.4.3 UK Status and Prospect (2012-2022)

1.4.4 Russia Status and Prospect (2012-2022)

1.4.5 Italy Status and Prospect (2012-2022)

1.4.6 Spain Status and Prospect (2012-2022)

1.4.7 Benelux Status and Prospect (2012-2022)

1.5 Europe Market Size (Value and Volume) of Non-Insulin Therapies for Diabetes (2012-2022)

1.5.1 Europe Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2022)

1.5.2 Europe Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2022)

2 Europe Non-Insulin Therapies for Diabetes by Manufacturers, Type and Application

2.1 Europe Non-Insulin Therapies for Diabetes Market Competition by Manufacturers

2.1.1 Europe Non-Insulin Therapies for Diabetes Sales and Market Share of Key Manufacturers (2015 and 2016)

2.1.2 Europe Non-Insulin Therapies for Diabetes Revenue and Share by Manufacturers (2015 and 2016)

2.2 Europe Non-Insulin Therapies for Diabetes (Volume and Value) by Type

2.2.1 Europe Non-Insulin Therapies for Diabetes Sales and Market Share by Type (2012-2017)

2.2.2 Europe Non-Insulin Therapies for Diabetes Revenue and Market Share by Type (2012-2017)

2.3 Europe Non-Insulin Therapies for Diabetes (Volume and Value) by Countries

2.3.1 Europe Non-Insulin Therapies for Diabetes Sales and Market Share by Countries (2012-2017)

2.3.2 Europe Non-Insulin Therapies for Diabetes Revenue and Market Share by Countries (2012-2017)

2.4 Europe Non-Insulin Therapies for Diabetes (Volume) by Application

3 Germany Non-Insulin Therapies for Diabetes (Volume, Value and Sales Price)

3.1 Germany Non-Insulin Therapies for Diabetes Sales and Value (2012-2017)

3.1.1 Germany Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2017)

3.1.2 Germany Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2017)

3.1.3 Germany Non-Insulin Therapies for Diabetes Sales Price Trend (2012-2017)

3.2 Germany Non-Insulin Therapies for Diabetes Sales and Market Share by Manufacturers

3.3 Germany Non-Insulin Therapies for Diabetes Sales and Market Share by Type

3.4 Germany Non-Insulin Therapies for Diabetes Sales and Market Share by Application

4 France Non-Insulin Therapies for Diabetes (Volume, Value and Sales Price)

4.1 France Non-Insulin Therapies for Diabetes Sales and Value (2012-2017)

4.1.1 France Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2017)

4.1.2 France Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2017)

4.1.4 France Non-Insulin Therapies for Diabetes Sales Price Trend (2012-2017)

4.2 France Non-Insulin Therapies for Diabetes Sales and Market Share by Manufacturers

4.3 France Non-Insulin Therapies for Diabetes Sales and Market Share by Type

4.4 France Non-Insulin Therapies for Diabetes Sales and Market Share by Application

5 UK Non-Insulin Therapies for Diabetes (Volume, Value and Sales Price)

5.1 UK Non-Insulin Therapies for Diabetes Sales and Value (2012-2017)

5.1.1 UK Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2017)

5.1.2 UK Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2017)

5.1.5 UK Non-Insulin Therapies for Diabetes Sales Price Trend (2012-2017)

5.2 UK Non-Insulin Therapies for Diabetes Sales and Market Share by Manufacturers

5.3 UK Non-Insulin Therapies for Diabetes Sales and Market Share by Type

5.4 UK Non-Insulin Therapies for Diabetes Sales and Market Share by Application

6 Russia Non-Insulin Therapies for Diabetes (Volume, Value and Sales Price)

6.1 Russia Non-Insulin Therapies for Diabetes Sales and Value (2012-2017)

6.1.1 Russia Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2017)

6.1.2 Russia Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2017)

6.1.6 Russia Non-Insulin Therapies for Diabetes Sales Price Trend (2012-2017)

6.2 Russia Non-Insulin Therapies for Diabetes Sales and Market Share by Manufacturers

6.3 Russia Non-Insulin Therapies for Diabetes Sales and Market Share by Type

6.4 Russia Non-Insulin Therapies for Diabetes Sales and Market Share by Application

7 Italy Non-Insulin Therapies for Diabetes (Volume, Value and Sales Price)

7.1 Italy Non-Insulin Therapies for Diabetes Sales and Value (2012-2017)

7.1.1 Italy Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2017)

7.1.2 Italy Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2017)

7.1.7 Italy Non-Insulin Therapies for Diabetes Sales Price Trend (2012-2017)

7.2 Italy Non-Insulin Therapies for Diabetes Sales and Market Share by Manufacturers

7.3 Italy Non-Insulin Therapies for Diabetes Sales and Market Share by Type

7.4 Italy Non-Insulin Therapies for Diabetes Sales and Market Share by Application

8 Spain Non-Insulin Therapies for Diabetes (Volume, Value and Sales Price)

8.1 Spain Non-Insulin Therapies for Diabetes Sales and Value (2012-2017)

8.1.1 Spain Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2017)

8.1.2 Spain Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2017)

8.1.8 Spain Non-Insulin Therapies for Diabetes Sales Price Trend (2012-2017)

8.2 Spain Non-Insulin Therapies for Diabetes Sales and Market Share by Manufacturers

8.3 Spain Non-Insulin Therapies for Diabetes Sales and Market Share by Type

8.4 Spain Non-Insulin Therapies for Diabetes Sales and Market Share by Application

9 Benelux Non-Insulin Therapies for Diabetes (Volume, Value and Sales Price)

9.1 Benelux Non-Insulin Therapies for Diabetes Sales and Value (2012-2017)

9.1.1 Benelux Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2017)

9.1.2 Benelux Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2017)

9.1.9 Benelux Non-Insulin Therapies for Diabetes Sales Price Trend (2012-2017)

9.2 Benelux Non-Insulin Therapies for Diabetes Sales and Market Share by Manufacturers

9.3 Benelux Non-Insulin Therapies for Diabetes Sales and Market Share by Type

9.4 Benelux Non-Insulin Therapies for Diabetes Sales and Market Share by Application

10 Europe Non-Insulin Therapies for Diabetes Manufacturers Analysis

10.1 GSK

10.1.1 Company Basic Information, Manufacturing Base and Competitors

10.1.2 Non-Insulin Therapies for Diabetes Product Type, Application and Specification

10.1.2.1 Alpha-Glucosidase Inhibitors

10.1.2.2 Amylin Agonists

10.1.3 GSK Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)

10.1.4 Main Business/Business Overview

10.2 Eli Lilly

10.2.1 Company Basic Information, Manufacturing Base and Competitors

10.2.2 Non-Insulin Therapies for Diabetes Product Type, Application and Specification

10.2.2.1 Alpha-Glucosidase Inhibitors

10.2.2.2 Amylin Agonists

10.2.3 Eli Lilly Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)

10.2.4 Main Business/Business Overview

10.3 Sumitomo Dainippon Pharma

10.3.1 Company Basic Information, Manufacturing Base and Competitors

10.3.2 Non-Insulin Therapies for Diabetes Product Type, Application and Specification

10.3.2.1 Alpha-Glucosidase Inhibitors

10.3.2.2 Amylin Agonists

10.3.3 Sumitomo Dainippon Pharma Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)

10.3.4 Main Business/Business Overview

10.4 Intarcia Therapeutics

10.4.1 Company Basic Information, Manufacturing Base and Competitors

10.4.2 Non-Insulin Therapies for Diabetes Product Type, Application and Specification

10.4.2.1 Alpha-Glucosidase Inhibitors

10.4.2.2 Amylin Agonists

10.4.3 Intarcia Therapeutics Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)

10.4.4 Main Business/Business Overview

10.5 Servier

10.5.1 Company Basic Information, Manufacturing Base and Competitors

10.5.2 Non-Insulin Therapies for Diabetes Product Type, Application and Specification

10.5.2.1 Alpha-Glucosidase Inhibitors

10.5.2.2 Amylin Agonists

10.5.3 Servier Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)

10.5.4 Main Business/Business Overview

10.6 Jiangsu Hansoh Pharmaceutical

10.6.1 Company Basic Information, Manufacturing Base and Competitors

10.6.2 Non-Insulin Therapies for Diabetes Product Type, Application and Specification

10.6.2.1 Alpha-Glucosidase Inhibitors

10.6.2.2 Amylin Agonists

10.6.3 Jiangsu Hansoh Pharmaceutical Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)

10.6.4 Main Business/Business Overview

10.7 Novo Nordisk

10.7.1 Company Basic Information, Manufacturing Base and Competitors

10.7.2 Non-Insulin Therapies for Diabetes Product Type, Application and Specification

10.7.2.1 Alpha-Glucosidase Inhibitors

10.7.2.2 Amylin Agonists

10.7.3 Novo Nordisk Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)

10.7.4 Main Business/Business Overview

10.8 Emisphere

10.8.1 Company Basic Information, Manufacturing Base and Competitors

10.8.2 Non-Insulin Therapies for Diabetes Product Type, Application and Specification

10.8.2.1 Alpha-Glucosidase Inhibitors

10.8.2.2 Amylin Agonists

10.8.3 Emisphere Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)

10.8.4 Main Business/Business Overview

10.9 Uni-Bio Science Group

10.9.1 Company Basic Information, Manufacturing Base and Competitors

10.9.2 Non-Insulin Therapies for Diabetes Product Type, Application and Specification

10.9.2.1 Alpha-Glucosidase Inhibitors

10.9.2.2 Amylin Agonists

10.9.3 Uni-Bio Science Group Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)

10.9.4 Main Business/Business Overview

10.10 Takeda

10.10.1 Company Basic Information, Manufacturing Base and Competitors

10.10.2 Non-Insulin Therapies for Diabetes Product Type, Application and Specification

10.10.2.1 Alpha-Glucosidase Inhibitors

10.10.2.2 Amylin Agonists

10.10.3 Takeda Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)

10.10.4 Main Business/Business Overview

10.11 3SBio

10.12 Merck

10.13 Dong-A Pharmaceutical

10.14 Luye Pharma Group

10.15 Eurofarma

10.16 Geropharm

10.17 Alkem Labs

10.18 SatRx

10.19 Pfizer

10.20 Jiangsu Hengrui Medicine

11 Non-Insulin Therapies for Diabetes Manufacturing Cost Analysis

11.1 Non-Insulin Therapies for Diabetes Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.1.2 Price Trend of Key Raw Materials

11.1.3 Key Suppliers of Raw Materials

11.1.4 Market Concentration Rate of Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Manufacturing Process Analysis of Non-Insulin Therapies for Diabetes

12 Industrial Chain, Sourcing Strategy and Downstream Buyers

12.1 Non-Insulin Therapies for Diabetes Industrial Chain Analysis

12.2 Upstream Raw Materials Sourcing

12.3 Raw Materials Sources of Non-Insulin Therapies for Diabetes Major Manufacturers in 2015

12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders

13.1 Marketing Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Development Trend

13.2 Market Positioning

13.2.1 Pricing Strategy

13.2.2 Brand Strategy

13.2.3 Target Client

13.3 Distributors/Traders List

14 Europe Non-Insulin Therapies for Diabetes Market Forecast (2017-2022)

14.1 Germany Non-Insulin Therapies for Diabetes Sales Forecast (2017-2022)

14.2 France Non-Insulin Therapies for Diabetes Sales Forecast (2017-2022)

14.3 UK Non-Insulin Therapies for Diabetes Sales Forecast (2017-2022)

14.4 Russia Non-Insulin Therapies for Diabetes Sales Forecast (2017-2022)

14.5 Italy Non-Insulin Therapies for Diabetes Sales Forecast (2017-2022)

14.6 Spain Non-Insulin Therapies for Diabetes Sales Forecast (2017-2022)

14.7 Benelux Non-Insulin Therapies for Diabetes Sales Forecast (2017-2022)

14.8 Europe Non-Insulin Therapies for Diabetes Sales Forecast by Type (2017-2022)

14.9 Europe Non-Insulin Therapies for Diabetes Sales Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix

Methodology

Analyst Introduction

Data Source

List of Tables and Figures

Figure Picture of Non-Insulin Therapies for Diabetes

Table Classification of Non-Insulin Therapies for Diabetes

Figure Europe Sales Market Share of Non-Insulin Therapies for Diabetes by Type in 2015

Figure Alpha-Glucosidase Inhibitors Picture

Figure Amylin Agonists Picture

Figure Biguanides Picture

Figure Dipeptidyl Peptidase-4 (DPP4) Inhibitors Picture

Figure Glinides/Meglitinides Picture

Figure GLP-1 Analogs/GLP-1 Agonists Picture

Figure Sodium-Glucose Cotransporter2(SGLT2)Inhibitors Picture

Figure Sulfonylureas Picture

Figure Thiazolidinediones Picture

Figure Others Picture

Table Application of Non-Insulin Therapies for Diabetes

Figure Europe Sales Market Share of Non-Insulin Therapies for Diabetes by Application in 2015

Figure Hospital Pharmacy Examples

Figure Retail Pharmacies Examples

Figure Online Pharmacy Examples

Figure Others Examples

Figure Germany Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2022)

Figure France Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2022)

Figure UK Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2022)

Figure Russia Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2022)

Figure Italy Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2022)

Figure Spain Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2022)

Figure Benelux Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2022)

Figure Europe Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2022)

Figure Europe Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2022)

Table Europe Non-Insulin Therapies for Diabetes Sales of Key Manufacturers (2015 and 2016)

Table Europe Non-Insulin Therapies for Diabetes Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Non-Insulin Therapies for Diabetes Sales Share by Manufacturers

Figure 2016 Non-Insulin Therapies for Diabetes Sales Share by Manufacturers

Table Europe Non-Insulin Therapies for Diabetes Revenue by Manufacturers (2015 and 2016)

Table Europe Non-Insulin Therapies for Diabetes Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Europe Non-Insulin Therapies for Diabetes Revenue Share by Manufacturers

Table 2016 Europe Non-Insulin Therapies for Diabetes Revenue Share by Manufacturers

Table Europe Non-Insulin Therapies for Diabetes Sales and Market Share by Type (2012-2017)

Table Europe Non-Insulin Therapies for Diabetes Sales Share by Type (2012-2017)

Figure Sales Market Share of Non-Insulin Therapies for Diabetes by Type (2012-2017)

Figure Europe Non-Insulin Therapies for Diabetes Sales Growth Rate by Type (2012-2017)

Table Europe Non-Insulin Therapies for Diabetes Revenue and Market Share by Type (2012-2017)

Table Europe Non-Insulin Therapies for Diabetes Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Non-Insulin Therapies for Diabetes by Type (2012-2017)

Figure Europe Non-Insulin Therapies for Diabetes Revenue Growth Rate by Type (2012-2017)

Table Europe Non-Insulin Therapies for Diabetes Sales and Market Share by Countries (2012-2017)

Table Europe Non-Insulin Therapies for Diabetes Sales Share by Countries (2012-2017)

Figure Sales Market Share of Non-Insulin Therapies for Diabetes by Countries (2012-2017)

Table Europe Non-Insulin Therapies for Diabetes Revenue and Market Share by Countries (2012-2017)

Table Europe Non-Insulin Therapies for Diabetes Revenue Share by Countries (2012-2017)

Figure Revenue Market Share of Non-Insulin Therapies for Diabetes by Countries (2012-2017)

Table Europe Non-Insulin Therapies for Diabetes Sales and Market Share by Application (2012-2017)

Table Europe Non-Insulin Therapies for Diabetes Sales Share by Application (2012-2017)

Figure Sales Market Share of Non-Insulin Therapies for Diabetes by Application (2012-2017)

Figure Germany Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2017)

Figure Germany Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2017)

Figure Germany Non-Insulin Therapies for Diabetes Sales Price Trend (2012-2017)

Table Germany Non-Insulin Therapies for Diabetes Sales by Manufacturers (2015 and 2016)

Table Germany Non-Insulin Therapies for Diabetes Market Share by Manufacturers (2015 and 2016)

Table Germany Non-Insulin Therapies for Diabetes Sales by Type (2015 and 2016)

Table Germany Non-Insulin Therapies for Diabetes Market Share by Type (2015 and 2016)

Table Germany Non-Insulin Therapies for Diabetes Sales by Application (2015 and 2016)

Table Germany Non-Insulin Therapies for Diabetes Market Share by Application (2015 and 2016)

Figure France Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2017)

Figure France Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2017)

Figure France Non-Insulin Therapies for Diabetes Sales Price Trend (2012-2017)

Table France Non-Insulin Therapies for Diabetes Sales by Manufacturers (2015 and 2016)

Table France Non-Insulin Therapies for Diabetes Market Share by Manufacturers (2015 and 2016)

Table France Non-Insulin Therapies for Diabetes Sales by Type (2015 and 2016)

Table France Non-Insulin Therapies for Diabetes Market Share by Type (2015 and 2016)

Table France Non-Insulin Therapies for Diabetes Sales by Application (2015 and 2016)

Table France Non-Insulin Therapies for Diabetes Market Share by Application (2015 and 2016)

Figure UK Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2017)

Figure UK Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2017)

Figure UK Non-Insulin Therapies for Diabetes Sales Price Trend (2012-2017)

Table UK Non-Insulin Therapies for Diabetes Sales by Manufacturers (2015 and 2016)

Table UK Non-Insulin Therapies for Diabetes Market Share by Manufacturers (2015 and 2016)

Table UK Non-Insulin Therapies for Diabetes Sales by Type (2015 and 2016)

Table UK Non-Insulin Therapies for Diabetes Market Share by Type (2015 and 2016)

Table UK Non-Insulin Therapies for Diabetes Sales by Application (2015 and 2016)

Table UK Non-Insulin Therapies for Diabetes Market Share by Application (2015 and 2016)

Figure Russia Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2017)

Figure Russia Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2017)

Figure Russia Non-Insulin Therapies for Diabetes Sales Price Trend (2012-2017)

Table Russia Non-Insulin Therapies for Diabetes Sales by Manufacturers (2015 and 2016)

Table Russia Non-Insulin Therapies for Diabetes Market Share by Manufacturers (2015 and 2016)

Table Russia Non-Insulin Therapies for Diabetes Sales by Type (2015 and 2016)

Table Russia Non-Insulin Therapies for Diabetes Market Share by Type (2015 and 2016)

Table Russia Non-Insulin Therapies for Diabetes Sales by Application (2015 and 2016)

Table Russia Non-Insulin Therapies for Diabetes Market Share by Application (2015 and 2016)

Figure Italy Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2017)

Figure Italy Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2017)

Figure Italy Non-Insulin Therapies for Diabetes Sales Price Trend (2012-2017)

Table Italy Non-Insulin Therapies for Diabetes Sales by Manufacturers (2015 and 2016)

Table Italy Non-Insulin Therapies for Diabetes Market Share by Manufacturers (2015 and 2016)

Table Italy Non-Insulin Therapies for Diabetes Sales by Type (2015 and 2016)

Table Italy Non-Insulin Therapies for Diabetes Market Share by Type (2015 and 2016)

Table Italy Non-Insulin Therapies for Diabetes Sales by Application (2015 and 2016)

Table Italy Non-Insulin Therapies for Diabetes Market Share by Application (2015 and 2016)

Figure Spain Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2017)

Figure Spain Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2017)

Figure Spain Non-Insulin Therapies for Diabetes Sales Price Trend (2012-2017)

Table Spain Non-Insulin Therapies for Diabetes Sales by Manufacturers (2015 and 2016)

Table Spain Non-Insulin Therapies for Diabetes Market Share by Manufacturers (2015 and 2016)

Table Spain Non-Insulin Therapies for Diabetes Sales by Type (2015 and 2016)

Table Spain Non-Insulin Therapies for Diabetes Market Share by Type (2015 and 2016)

Table Spain Non-Insulin Therapies for Diabetes Sales by Application (2015 and 2016)

Table Spain Non-Insulin Therapies for Diabetes Market Share by Application (2015 and 2016)

Figure Benelux Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2017)

Figure Benelux Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2017)

Figure Benelux Non-Insulin Therapies for Diabetes Sales Price Trend (2012-2017)

Table Benelux Non-Insulin Therapies for Diabetes Sales by Manufacturers (2015 and 2016)

Table Benelux Non-Insulin Therapies for Diabetes Market Share by Manufacturers (2015 and 2016)

Table Benelux Non-Insulin Therapies for Diabetes Sales by Type (2015 and 2016)

Table Benelux Non-Insulin Therapies for Diabetes Market Share by Type (2015 and 2016)

Table Benelux Non-Insulin Therapies for Diabetes Sales by Application (2015 and 2016)

Table Benelux Non-Insulin Therapies for Diabetes Market Share by Application (2015 and 2016)

Table Non-Insulin Therapies for Diabetes Basic Information List

Table GSK Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)

Figure GSK Non-Insulin Therapies for Diabetes Sales Market Share (2012-2017)

Table Eli Lilly Basic Information List

Table Eli Lilly Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)

Table Eli Lilly Non-Insulin Therapies for Diabetes Sales Market Share (2012-2017)

Table Sumitomo Dainippon Pharma Basic Information List

Table Sumitomo Dainippon Pharma Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)

Table Sumitomo Dainippon Pharma Non-Insulin Therapies for Diabetes Sales Market Share (2012-2017)

Table Intarcia Therapeutics Basic Information List

Table Intarcia Therapeutics Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)

Table Intarcia Therapeutics Non-Insulin Therapies for Diabetes Sales Market Share (2012-2017)

Table Servier Basic Information List

Table Servier Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)

Table Servier Non-Insulin Therapies for Diabetes Sales Market Share (2012-2017)

Table Jiangsu Hansoh Pharmaceutical Basic Information List

Table Jiangsu Hansoh Pharmaceutical Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)

Table Jiangsu Hansoh Pharmaceutical Non-Insulin Therapies for Diabetes Sales Market Share (2012-2017)

Table Novo Nordisk Basic Information List

Table Novo Nordisk Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)

Table Novo Nordisk Non-Insulin Therapies for Diabetes Sales Market Share (2012-2017)

Table Emisphere Basic Information List

Table Emisphere Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)

Table Emisphere Non-Insulin Therapies for Diabetes Sales Market Share (2012-2017)

Table Uni-Bio Science Group Basic Information List

Table Uni-Bio Science Group Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)

Table Uni-Bio Science Group Non-Insulin Therapies for Diabetes Sales Market Share (2012-2017)

Table Takeda Basic Information List

Table Takeda Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)

Table Takeda Non-Insulin Therapies for Diabetes Sales Market Share (2012-2017)

Table 3SBio Basic Information List

Table Merck Basic Information List

Table Dong-A Pharmaceutical Basic Information List

Table Luye Pharma Group Basic Information List

Table Eurofarma Basic Information List

Table Geropharm Basic Information List

Table Alkem Labs Basic Information List

Table SatRx Basic Information List

Table Pfizer Basic Information List

Table Jiangsu Hengrui Medicine Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Non-Insulin Therapies for Diabetes

Figure Manufacturing Process Analysis of Non-Insulin Therapies for Diabetes

Figure Non-Insulin Therapies for Diabetes Industrial Chain Analysis

Table Raw Materials Sources of Non-Insulin Therapies for Diabetes Major Manufacturers in 2015

Table Major Buyers of Non-Insulin Therapies for Diabetes

Table Distributors/Traders List

Figure Germany Non-Insulin Therapies for Diabetes Sales and Growth Rate Forecast (2017-2022)

Figure Germany Non-Insulin Therapies for Diabetes Revenue and Growth Rate Forecast (2017-2022)

Figure France Non-Insulin Therapies for Diabetes Sales and Growth Rate Forecast (2017-2022)

Figure France Non-Insulin Therapies for Diabetes Revenue and Growth Rate Forecast (2017-2022)

Figure UK Non-Insulin Therapies for Diabetes Sales and Growth Rate Forecast (2017-2022)

Figure UK Non-Insulin Therapies for Diabetes Revenue and Growth Rate Forecast (2017-2022)

Figure Russia Non-Insulin Therapies for Diabetes Sales and Growth Rate Forecast (2017-2022)

Figure Russia Non-Insulin Therapies for Diabetes Revenue and Growth Rate Forecast (2017-2022)

Figure Italy Non-Insulin Therapies for Diabetes Sales and Growth Rate Forecast (2017-2022)

Figure Italy Non-Insulin Therapies for Diabetes Revenue and Growth Rate Forecast (2017-2022)

Figure Spain Non-Insulin Therapies for Diabetes Sales and Growth Rate Forecast (2017-2022)

Figure Spain Non-Insulin Therapies for Diabetes Revenue and Growth Rate Forecast (2017-2022)

Figure Benelux Non-Insulin Therapies for Diabetes Sales and Growth Rate Forecast (2017-2022)

Figure Benelux Non-Insulin Therapies for Diabetes Revenue and Growth Rate Forecast (2017-2022)

Table Europe Non-Insulin Therapies for Diabetes Sales Forecast by Type (2017-2022)

Table Europe Non-Insulin Therapies for Diabetes Sales Forecast by Application (2017-2022)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370